Literature DB >> 12051934

Initiation factor IF2, thiostrepton and micrococcin prevent the binding of elongation factor G to the Escherichia coli ribosome.

Dale M Cameron1, Jill Thompson, Paul E March, Albert E Dahlberg.   

Abstract

The bacterial translational GTPases (initiation factor IF2, elongation factors EF-G and EF-Tu and release factor RF3) are involved in all stages of translation, and evidence indicates that they bind to overlapping sites on the ribosome, whereupon GTP hydrolysis is triggered. We provide evidence for a common ribosomal binding site for EF-G and IF2. IF2 prevents the binding of EF-G to the ribosome, as shown by Western blot analysis and fusidic acid-stabilized EF-G.GDP.ribosome complex formation. Additionally, IF2 inhibits EF-G-dependent GTP hydrolysis on 70 S ribosomes. The antibiotics thiostrepton and micrococcin, which bind to part of the EF-G binding site and interfere with the function of the factor, also affect the function of IF2. While thiostrepton is a strong inhibitor of EF-G-dependent GTP hydrolysis, GTP hydrolysis by IF2 is stimulated by the drug. Micrococcin stimulates GTP hydrolysis by both factors. We show directly that these drugs act by destabilizing the interaction of EF-G with the ribosome, and provide evidence that they have similar effects on IF2.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12051934     DOI: 10.1016/S0022-2836(02)00235-8

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  35 in total

1.  Common and distinctive features of GNRA tetraloops based on a GUAA tetraloop structure at 1.4 A resolution.

Authors:  Carl C Correll; Kerren Swinger
Journal:  RNA       Date:  2003-03       Impact factor: 4.942

2.  Manipulation of thiocillin variants by prepeptide gene replacement: structure, conformation, and activity of heterocycle substitution mutants.

Authors:  Albert A Bowers; Michael G Acker; Alexander Koglin; Christopher T Walsh
Journal:  J Am Chem Soc       Date:  2010-06-02       Impact factor: 15.419

3.  The common and the distinctive features of the bulged-G motif based on a 1.04 A resolution RNA structure.

Authors:  Carl C Correll; Jutta Beneken; Matthew J Plantinga; Melissa Lubbers; Yuen-Ling Chan
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

Review 4.  Ribosomal protection proteins and their mechanism of tetracycline resistance.

Authors:  Sean R Connell; Dobryan M Tracz; Knud H Nierhaus; Diane E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

5.  EF-G-independent reactivity of a pre-translocation-state ribosome complex with the aminoacyl tRNA substrate puromycin supports an intermediate (hybrid) state of tRNA binding.

Authors:  Divya Sharma; Daniel R Southworth; Rachel Green
Journal:  RNA       Date:  2004-01       Impact factor: 4.942

Review 6.  After the ribosome structure: how does translocation work?

Authors:  Simpson Joseph
Journal:  RNA       Date:  2003-02       Impact factor: 4.942

7.  A dedicated translation factor controls the synthesis of the global regulator Fis.

Authors:  Róisín M Owens; Gareth Pritchard; Paul Skipp; Michelle Hodey; Sean R Connell; Knud H Nierhaus; C David O'Connor
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

Review 8.  Initiation of protein synthesis in bacteria.

Authors:  Brian Søgaard Laursen; Hans Peter Sørensen; Kim Kusk Mortensen; Hans Uffe Sperling-Petersen
Journal:  Microbiol Mol Biol Rev       Date:  2005-03       Impact factor: 11.056

9.  Recognition of ribosomal protein L11 by the protein trimethyltransferase PrmA.

Authors:  Hasan Demirci; Steven T Gregory; Albert E Dahlberg; Gerwald Jogl
Journal:  EMBO J       Date:  2007-01-11       Impact factor: 11.598

10.  Antimicrobial evaluation of nocathiacins, a thiazole peptide class of antibiotics.

Authors:  Michael J Pucci; Joanne J Bronson; John F Barrett; Kenneth L DenBleyker; Linda F Discotto; Joan C Fung-Tomc; Yasutsugu Ueda
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.